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Murine Model for Human SPR Deﬁciency, by Yang et
al. (p. 575)
Sepiapterin-reductase (SPR) is a member of the intricate
network of enzymes necessary for the homeostasis of the
essential cofactor tetrahydrobiopterin (BH4). Patients
with BH4 deﬁciency can develop a variety of neuro-
muscular symptoms because of a decrease in activity of
enzymes such as phenylalanine-4-hydroxylase (PAH), ty-
rosine-3-hydroxylase (TH), and tryptophan-5-hydrox-
ylase (TPH). Though it was originally thought that
mechanisms existed that compensated for loss of SPR,
patients have recently been identiﬁed with SPR deﬁ-
ciency who have psychomotor retardation, spasticity,
dystonia, tremors, and growth retardation. Yang et al.
create a mouse model for SPR deﬁciency to study the
pathways affected by the loss of the protein. Like the
patients, the mice also show growth retardation and im-
paired body movement. BH4 levels are signiﬁcantly re-
duced, and, consequently, the activity of PAH, TH, and
TPH is impaired. The authors then demonstrate that
dietary supplementation of BH4 is able to restore normal
body growth and PAH activity. These mice will serve as
a resource for additional studies of the effects of SPR
deﬁciency and as a model for the progression of the
human disease.
A Fine-Scale LD Measure, by Wang et al. (p. 615)
As high-throughput SNP genotyping technologies im-
prove, more information is available to map complex
diseases, study recombination, and analyze the genetic
relationships within and among populations. It is im-
portant for these analyses that the linkage disequilibrium
in a genomic region be accurately assessed. Traditionally,
the two-point measures, D′ and r2, are used, but these
statistics are not very robust to marker allele frequency
and are highly variable across the physical distance be-
tween two markers. Wang et al. propose a new measure,
D, that incorporates information from surrounding al-
leles to estimate common ancestral segments from shared
haplotypes. In simulation studies, the authors demon-
strate how smoothly D correlates with physical distance
and how correct values are obtained at a variety of
marker densities and frequencies. They also expand their
simulations to establish conditions for using unphased
genotypes. The three measures are then compared on
real data from the HapMap project, and D is able to
precisely correlate the LD of the region with physical
distance and recombination rate. This new statistic
should assist in making more-detailed measurements of
LD throughout the genome.
Reinitiation of Translation in NEMO, by Puel et al. (p.
691)
NF-kB essential modulator (NEMO) is necessary for
normal NF-kB activation. Inactivating NEMO muta-
tions cause incontinentia pigmenti (IP), a severe devel-
opmental disorder that causes death in utero in hemi-
zygous males and various ectoderm abnormalities in
heterozygous females. Hypomorphic mutations are as-
sociated with forms of anhidrotic ectodermal dysplasia
(EDA) and immunodeﬁciency (ID). Peul et al. report a
patient with a NEMO frameshift mutation that causes
the most 5′ truncation yet identiﬁed. On the basis of
analysis of the truncated protein alone, the new patient
would be expected to suffer from IP but instead has ID
without any obvious developmental defects. The authors
explain the comparatively mild phenotype by demon-
strating that an alternative downstream NEMO start
codon is utilized. The smaller protein produced from
this new start site is observed at low levels in wild-type
and mutant cells. The variant protein is able to normally
activate NF-kB and retains some kB DNA-binding ac-
tivity but is unable to elicit a proper immunological re-
sponse. This is an example of how reinitiation of trans-
lation of a mutant transcript can partially recapitulate
normal protein function.
Mutation in RAB3GAP2 and Martsolf Syndrome, by
Aligianis et al. (p. 702)
Martsolf syndrome and Warburg Micro syndrome are
characterized by ocular and neurodevelopmental de-
fects. Recently, mutations in RAB3GAP1 were identiﬁed
in a subset of Warburg Micro kindreds. RAB3GAP1
encodes the catalytic subunit of the RAB3GAP protein
complex, a regulator of proteins involved in the exoc-
tyosis of hormones and neurotransmitters. The other
subunit is encoded by RAB3GAP2. Because of the sim-
ilarities between Martsolf syndrome and Warburg Mi-
cro syndrome, Aligianis et al. look for linkage to
RAB3GAP1 in a family with a Martsolf-like pheno-
type. The RAB3GAP1 locus is excluded, but the authors
do ﬁnd evidence for linkage to the region containing
RAB3GAP2. Sequencing of the gene identiﬁes a ho-
mozygous mutation in the affected members of the
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family. Expression analysis in zebraﬁsh embryos then
provides additional clues about the role of these pro-
teins in development. Though RAB3GAP1 is gener-
ally expressed throughout the embryo, its partner,
RAB3GAP2, localizes to speciﬁc regions of the CNS.
This restricted expression helps to explain the phenotype
that results from the disruption of either subunit of the
RAB3GAP protein.
The Power To Detect Disease Associations with
mtDNA Haplogroups, by Samuels et al. (p. 713)
Mitochondrial DNA (mtDNA) sequences are often bro-
ken down into haplogroups on the basis of variation at
speciﬁc SNPs. Human populations can be divided into
these mitochondrial categories, and, for example, ∼95%
of Europeans belong to 1 of 10 haplogroups. A great
deal of work has been done to compare haplogroup
frequencies in cases and controls, to propose links be-
tween mtDNA variation and a number of disorders. Yet,
as with any type of association study, even highly sig-
niﬁcant ﬁndings are difﬁcult to replicate. Although other
reasons may explain this lack of reproducibility in cer-
tain cases, Samuels et al. examine the power that is
achievable in mtDNA studies. Their ﬁrst analysis details
the risk of generating false positives when analyzing in-
frequent haplogroups. Then, by simulating populations
with varying haplogroup frequencies, the authors estab-
lish that very large cohorts are needed to have enough
power to identify signiﬁcant associations. These conclu-
sions not only help to explain discrepancies among past
studies but also will assist in future efﬁcient study design.
This Month on the Cover
Archibald E. Garrod, commonly referred to as “the fa-
ther of biochemical genetics,” was one of the ﬁrst ge-
neticists to recognize “inborn errors of metabolism.” In
1902, he described the incidence of alkaptonuria in nine
families (Garrod AE [1902] Lancet 2:1616–1630). Gar-
rod noted that a high proportion of the patients were
born to consanguineous parents, and this, with the ob-
servations of Bateson et al. (Bateson W, Sunders ER
[1902] Report to the Evolution Committee of the Royal
Society 1:133), helped to predict that the disorder was
due to the transmission of a rare recessive allele. Garrod
observed that urine from alkaptonuria patients darkens
on exposure to air or with the addition of base. Special
thanks to Dr. Bill Gahl and Isa Bernardini for the
photograph.
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